185 related articles for article (PubMed ID: 37175615)
1. Overexpression of miR-4669 Enhances Tumor Aggressiveness and Generates an Immunosuppressive Tumor Microenvironment in Hepatocellular Carcinoma: Its Clinical Value as a Predictive Biomarker.
Nakano T; Chen CL; Chen IH; Tseng HP; Chiang KC; Lai CY; Hsu LW; Goto S; Lin CC; Cheng YF
Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175615
[TBL] [Abstract][Full Text] [Related]
2. Acidic Microenvironment Up-Regulates Exosomal miR-21 and miR-10b in Early-Stage Hepatocellular Carcinoma to Promote Cancer Cell Proliferation and Metastasis.
Tian XP; Wang CY; Jin XH; Li M; Wang FW; Huang WJ; Yun JP; Xu RH; Cai QQ; Xie D
Theranostics; 2019; 9(7):1965-1979. PubMed ID: 31037150
[No Abstract] [Full Text] [Related]
3. Hepatocellular carcinoma cell-derived exosomal miR-21-5p promotes the polarization of tumor-related macrophages (TAMs) through SP1/XBP1 and affects the progression of hepatocellular carcinoma.
Hu Z; You L; Hu S; Yu L; Gao Y; Li L; Zhang S
Int Immunopharmacol; 2024 Jan; 126():111149. PubMed ID: 38006750
[TBL] [Abstract][Full Text] [Related]
4. Exosomal MiR-744 Inhibits Proliferation and Sorafenib Chemoresistance in Hepatocellular Carcinoma by Targeting PAX2.
Wang G; Zhao W; Wang H; Qiu G; Jiang Z; Wei G; Li X
Med Sci Monit; 2019 Sep; 25():7209-7217. PubMed ID: 31553714
[TBL] [Abstract][Full Text] [Related]
5. Circulating exosomal miR-92b: Its role for cancer immunoediting and clinical value for prediction of posttransplant hepatocellular carcinoma recurrence.
Nakano T; Chen IH; Wang CC; Chen PJ; Tseng HP; Huang KT; Hu TH; Li LC; Goto S; Cheng YF; Lin CC; Chen CL
Am J Transplant; 2019 Dec; 19(12):3250-3262. PubMed ID: 31162867
[TBL] [Abstract][Full Text] [Related]
6. Exosomal miR-452-5p Induce M2 Macrophage Polarization to Accelerate Hepatocellular Carcinoma Progression by Targeting TIMP3.
Zongqiang H; Jiapeng C; Yingpeng Z; Chuntao Y; Yiting W; Jiashun Z; Li L
J Immunol Res; 2022; 2022():1032106. PubMed ID: 36164322
[TBL] [Abstract][Full Text] [Related]
7. Cancer-associated fibroblasts promote hepatocellular carcinoma progression through downregulation of exosomal miR-150-3p.
Yugawa K; Yoshizumi T; Mano Y; Itoh S; Harada N; Ikegami T; Kohashi K; Oda Y; Mori M
Eur J Surg Oncol; 2021 Feb; 47(2):384-393. PubMed ID: 32883551
[TBL] [Abstract][Full Text] [Related]
8. Human umbilical cord mesenchymal stem cells-derived exosomal microRNA-451a represses epithelial-mesenchymal transition of hepatocellular carcinoma cells by inhibiting ADAM10.
Xu Y; Lai Y; Cao L; Li Y; Chen G; Chen L; Weng H; Chen T; Wang L; Ye Y
RNA Biol; 2021 Oct; 18(10):1408-1423. PubMed ID: 33206588
[TBL] [Abstract][Full Text] [Related]
9. Exosomal miR-200b-3p induce macrophage polarization by regulating transcriptional repressor ZEB1 in hepatocellular carcinoma.
Xu Y; Luan G; Liu F; Zhang Y; Li Z; Liu Z; Yang T
Hepatol Int; 2023 Aug; 17(4):889-903. PubMed ID: 36930410
[TBL] [Abstract][Full Text] [Related]
10. Synthetic miR-26a mimics delivered by tumor exosomes repress hepatocellular carcinoma through downregulating lymphoid enhancer factor 1.
Hu J; Liu WF; Zhang XY; Shi GM; Yang XR; Zhou KQ; Hu B; Chen FY; Zhou C; Lau WY; Fan J; Wang Z; Zhou J
Hepatol Int; 2023 Oct; 17(5):1265-1278. PubMed ID: 37115456
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of serum exosomal miR-320d predicts poor prognosis in hepatocellular carcinoma.
Li W; Ding X; Wang S; Xu L; Yin T; Han S; Geng J; Sun W
J Clin Lab Anal; 2020 Jun; 34(6):e23239. PubMed ID: 32125733
[TBL] [Abstract][Full Text] [Related]
12. Exosomal DLX6-AS1 from hepatocellular carcinoma cells induces M2 macrophage polarization to promote migration and invasion in hepatocellular carcinoma through microRNA-15a-5p/CXCL17 axis.
Wang LP; Lin J; Ma XQ; Xu DY; Shi CF; Wang W; Jiang XJ
J Exp Clin Cancer Res; 2021 May; 40(1):177. PubMed ID: 34039401
[TBL] [Abstract][Full Text] [Related]
13. Exosomal miR-451a Functions as a Tumor Suppressor in Hepatocellular Carcinoma by Targeting LPIN1.
Zhao S; Li J; Zhang G; Wang Q; Wu C; Zhang Q; Wang H; Sun P; Xiang R; Yang S
Cell Physiol Biochem; 2019; 53(1):19-35. PubMed ID: 31162914
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia-induced exosomes promote hepatocellular carcinoma proliferation and metastasis via miR-1273f transfer.
Yu Y; Min Z; Zhou Zhihang ; Linhong M; Tao R; Yan L; Song H
Exp Cell Res; 2019 Dec; 385(1):111649. PubMed ID: 31562861
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of exosomal microRNA-224 in development of hepatocellular carcinoma and its diagnostic and prognostic value.
Cui Y; Xu HF; Liu MY; Xu YJ; He JC; Zhou Y; Cang SD
World J Gastroenterol; 2019 Apr; 25(15):1890-1898. PubMed ID: 31057302
[TBL] [Abstract][Full Text] [Related]
16. Jianpi Huayu decoction inhibits the epithelial-mesenchymal transition of hepatocellular carcinoma cells by suppressing exosomal miR-23a-3p/Smad signaling.
Xie CF; Feng KL; Wang JN; Luo R; Fang CK; Zhang Y; Shen CP; Zhong C
J Ethnopharmacol; 2022 Aug; 294():115360. PubMed ID: 35568116
[TBL] [Abstract][Full Text] [Related]
17. Exosome-mediated circTTLL5 transfer promotes hepatocellular carcinoma malignant progression through miR-136-5p/KIAA1522 axis.
Liu C; Ren C; Guo L; Yang C; Yu Q
Pathol Res Pract; 2023 Jan; 241():154276. PubMed ID: 36528986
[TBL] [Abstract][Full Text] [Related]
18. Exosomes secreted by M2 macrophages promote cancer stemness of hepatocellular carcinoma via the miR-27a-3p/TXNIP pathways.
Li W; Xin X; Li X; Geng J; Sun Y
Int Immunopharmacol; 2021 Dec; 101(Pt A):107585. PubMed ID: 34601333
[TBL] [Abstract][Full Text] [Related]
19. Tumour-derived exosomal lncRNA SNHG16 induces telocytes to promote metastasis of hepatocellular carcinoma via the miR-942-3p/MMP9 axis.
Xu Y; Luan G; Li Z; Liu Z; Qin G; Chu Y
Cell Oncol (Dordr); 2023 Apr; 46(2):251-264. PubMed ID: 36434360
[TBL] [Abstract][Full Text] [Related]
20. Exosomal lncRNA HMMR-AS1 mediates macrophage polarization through miR-147a/ARID3A axis under hypoxia and affects the progression of hepatocellular carcinoma.
Wang X; Zhou Y; Dong K; Zhang H; Gong J; Wang S
Environ Toxicol; 2022 Jun; 37(6):1357-1372. PubMed ID: 35179300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]